🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2 trial in which participants with chronic hepatitis D viru...
Status
Active Not Recruiting
Location
Investigative Site
Start Date
2022-09-17
Trial ID
NCT05461170
This is a phase 1/2 study in which healthy adult subjects and subjects with...
Status
Completed
Location
Investigative Site
Start Date
2018-11-14
Trial ID
NCT03672188
This is an open label, randomized, parallel-group study to evaluate the saf...
Status
Completed
Location
Investigative Site 61002
Start Date
2021-04-12
Trial ID
NCT04749368
Treatments Being Tested
A Study to Evaluate Tobevibart+Elebsiran versus Bulevirtide in Chronic HDV ...
Status
Active Not Recruiting
Location
Investigative Site
Start Date
2025-08-05
Trial ID
NCT07142811
Treatments Being Tested
Background: Chronic hepatitis B virus (HBV) infection affects 292 million ...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2025-01-31
Trial ID
NCT06092333
Treatments Being Tested
The rationale of this study is to evaluate the impact of renal function on ...
Status
Completed
Location
Inland Empire Clinical Trials
Start Date
2023-06-01
Trial ID
NCT05844228
Treatments Being Tested
This study is to evaluate the safety, pharmacokinetics characteristics, and...
Status
Completed
Location
Investigative Site
Start Date
2020-08-18
Trial ID
NCT04507269
This is a phase 2 study in which participants with chronic hepatitis B viru...
Status
Completed
Location
Investigative Site
Start Date
2021-07-11
Trial ID
NCT04856085
This Phase 2, randomized, double-blind study will evaluate the clinical eff...
Status
Recruiting
Location
Investigative Site 86001
Start Date
2024-10-31
Trial ID
NCT06650852
Treatments Being Tested
This Phase 1b clinical study is a multi-center, open-label, dose escalation...
Status
Completed
Location
Chinese University of Hong Kong
Start Date
2023-09-26
Trial ID
NCT06070051
Treatments Being Tested